skip to Main Content

Introducing Thyroid GuidePx®

Helping guide your papillary thyroid cancer treatment journey!

Learn More

Thyroid GuidePx® is a prognostic test for papillary thyroid cancer

Thyroid GuidePx® is performed on next generation sequencing (RNASeq). The test provides a molecular subclassification of papillary thyroid cancer that is based on the expression of 82 genes.

Thyroid GuidePx® simplifies prognostication, and identifies a low risk group with <3% recurrence rate. The test outperforms the American thyroid Association Clinical Risk Stratification System.

Enter Your Contact Information Below To Receive A Sample Patient Report

"*" indicates required fields

This field is for validation purposes and should be left unchanged.